Medacta Australia Pty Revenue and Competitors

Lane Cove, Australia

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Medacta Australia Pty's estimated annual revenue is currently $28.9M per year.(i)
  • Medacta Australia Pty's estimated revenue per employee is $270,000

Employee Data

  • Medacta Australia Pty has 107 Employees.(i)
  • Medacta Australia Pty grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$42.8M14420%N/AN/A
#2
$108M32020%N/AN/A
#3
$161M4774%N/AN/A
#4
$79M26649%N/AN/A
#5
$23.8M88-2%N/AN/A
#6
$45.1M15223%N/AN/A
#7
$228.5M67716%N/AN/A
#8
$60.9M20527%N/AN/A
#9
$51.1M1727%N/AN/A
#10
$14.3M5911%N/AN/A
Add Company

MISSION - To allow patients to regain a healthier and more active lifestyle through products and services which make surgery and rehabilitation faster, more effective and less painful. Headquartered in Switzerland with branch offices in over 21 countries Medacta Australia® is global partner of the privately owned 'Medacta International®'; a global leader in orthopaedic hip and knee medical device production and sales. INNOVATION - We are looking to the future: Innovation is our key product, the way to our present and future success and the strategy to grow in a competitive market. Innovation is the foundation of all our projects; it guides us and is reflected in the originality of our internationally patented products. Medacta® is synonymous with collaboration with surgeons worldwide; Medacta® represents a new opportunity for the orthopaedic industry. STRONG - There are no compromises: Quality in Motion is our motto. In all circumstances, the Quality of Medacta®'s products is paramount; every effort is made to avoid any risks to our patients. Our aim is to offer premium value for our products and to adhere to all the standards and regulations governing our activities, through a rigorous Quality Policy which is a philosophy of life that all Medacta®'s employees share and are motivated to achieve.

keywords:N/A

N/A

Total Funding

107

Number of Employees

$28.9M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medacta Australia Pty News

2022-04-17 - Mercado global de implantes de rejuvenecimiento de cadera 2022 ...

... Elite Surgical Supplies (PTY), Euros France, Evolutis, FH Orthopaedics, Integra LifeSciences, Lima Corporativo, Medacta, Ortosintese,...

2021-10-19 - Medacta : extends the personalized medicine concept to total knee revision surgeries with the unique and innovative MyKnee R patient-specific solution Read More >

Media release Medacta extends the personalized medicine concept to total knee revision surgeries with the unique and innovative MyKnee R patient-specific solution CASTEL SAN PIETRO, 19 October 2021 - Medacta announces the release of MyKnee(R) R, the newest addition to its MySolutions(R) Person ...

2021-09-29 - Medacta : First Surgery with Medacta's Minimally Invasive M.U.S.T. MC Platform Read More >

Media release First Surgery with Medacta's Minimally Invasive M.U.S.T. MC Platform CASTEL SAN PIETRO, Switzerland, September 29, 2021 - Medacta proudly announces Ivan LaMotta, M.D. of Midlands Orthopaedics & Neurosurgery in Columbia, South Carolina successfully completed the first posterior lu ...

2021-09-09 - Medacta : Expands its Sports Medicine Innovative Portfolio with a Full Line of New Products

After receiving several U.S. Food and Drug Administration (FDA) and Australia's Therapeutic Goods Administration (TGA) registrations, Medacta has obtained multiple CE markings and expanded its indications in arthroscopic knee, shoulder, and hip surgery. The recent registrations[1], together with ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$36.1M111-24%N/A
#2
$16.4M113N/AN/A
#3
$15M1317%N/A
#4
$16.5M150-20%N/A
#5
$25.6M166N/AN/A